Astrana Health, Inc.

ASTH Healthcare Medical Care Facilities

Astrana Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 56.4% from fiscal 2024. In the quarter to June 2026, revenue grew 48.5%, EPS grew 110.5%, free cash flow fell 67.7% and total debt rose 126.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

36.81 1.22 −3.21%
Market cap
$1.9B
P/E
44.3×
Fwd P/E
29.7×
Dividend yield
—
F-score
4/9
Altman Z
2.39
Beneish M
−2.19
Dividend safety
50/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

149.21 53.93 39.55 55.92
P/S ratio
0.48 0.38 0.34 0.59
P/FCF ratio
14.39 11.65 7.73 24.15
P/Operating CF
140.16 (421.89) 17.60 69.61
P/B ratio
1.77 1.53 1.47 2.71
EV/Sales
0.68 0.57 0.50 0.73
EV/EBITDA
19.49 14.24 12.02 16.75
EV/FCF
20.44 17.48 11.27 29.83
Current Ratio
1.40 1.40 1.35 1.23
Net Debt/EBITDA
16.31 16.95 12.17 10.50
Debt/Equity
1.33 1.31 1.26 1.11
Earnings Yield
0.67% 1.85% 2.53% 1.79%
Free Cash Flow Yield
6.95% 8.58% 12.94% 4.14%
Free Cash Flow per Share
0.15 (0.12) 1.31 0.59
Book value per Share
16.03 16.16 16.69 17.12
Free Cash Flow
7.40 (5.95) 64.06 28.87
EV/EBIT
32.57 23.26 20.21 28.03
Other line items

Show all line items

Columns are period end dates